VORGEFÜLLTE SPRITZE

Patent europeic · EP1276525 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP1276525
Numer da la dumonda
EP01915551
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
28-03-2001
Publitgà
22-01-2003
Concedì
14-09-2005
Stritgà
27-03-2021
Motiv
Durada maximala cuntanschida
Classas IPC
A61M 5/28 (2006.01)
A61M 5/34 (2006.01)
A61M 5/31 (2006.01)
Prioritad
JP 2000105386 03.04.2000
Dumonda PCT
PCT/GB2001/001433 28.03.2001
Publicaziun PCT
WO2001/074424 11.10.2001
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 29-03-2021

    Durada maximala cuntanschida

    Published in Swissreg on 29.03.2021

  2. 13-02-2018

    Transferì

    Owner
    AstraZeneca UK Limited, 15 Stanhope Gate, London W1Y 6LN, United Kingdom → Aspen Global Incorporated, GBS Plaza, Cnr La Salette and Royal Roads, Grand Bay, Mauritius

    Published in Swissreg on 13.02.2018

  3. 13-02-2018

    Represchentant inscrit

    Representative
    Patentanwälte, Schaad, Balass, Menzl & Partner AG, Dufourstrasse 101, 8034 Zürich

    Published in Swissreg on 13.02.2018

  4. 15-09-2005

    Concedì

    Published in +pat+ No 17 in 2005

Partidas

Inventur

HENDERSON, Malcolm, John

Cheshire SK10 4TG, GB

HIRAYAMA, Toshikazu Nissho Co. Limited

Osaka, JP

ARAMATA, Masafumi Nissho Co. Limited

Osaka, JP

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.